thumbnail

Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis)

Vaccine

By:
, , , , , , and
DOI: 10.1016/j.vaccine.2009.10.043

Links

Abstract

In previous studies, we demonstrated protection against plague in mice and prairie dogs using a raccoon pox (RCN) virus-vectored vaccine that expressed the F1 capsular antigen of Yersinia pestis. In order to improve vaccine efficacy, we have now constructed additional RCN-plague vaccines containing two different forms of the lcrV (V) gene, including full-length (Vfull) and a truncated form (V307). Mouse challenge studies with Y. pestis strain CO92 showed that vaccination with a combination of RCN-F1 and the truncated V construct (RCN-V307) provided the greatest improvement (P = 0.01) in protection against plague over vaccination with RCN-F1 alone. This effect was mediated primarily by anti-F1 and anti-V antibodies and both contributed independently to increased survival of vaccinated mice.

Additional Publication Details

Publication type:
Article
Publication Subtype:
Journal Article
Title:
Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis)
Series title:
Vaccine
DOI:
10.1016/j.vaccine.2009.10.043
Volume
28
Issue:
2
Year Published:
2009
Language:
English
Larger Work Type:
Article
Larger Work Subtype:
Journal Article
Larger Work Title:
Vaccine
First page:
338
Last page:
344
Number of Pages:
7